April 14, 2024

Igor Kutyaev/iStock through Getty Photographs

Prime Drugs (NASDAQ:PRME) is on the forefront of gene modifying, advancing the boundaries of genetic therapies with its progressive Prime Modifying platform. Nonetheless, the potential of this know-how is greater than only a